SC
NUVL

Stempoint Capital’s Nuvalent NUVL Stock Holding History

Stempoint Capital’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-59,828
Closed -$4.56M – 95
2025
Q2 		$4.56M Sell
59,828
-130,573
-69% -$9.55M 1.47% 23
2025
Q1 		$13.5M Buy
190,401
+45,167
+31% +$3.53M 4.3% 8
2024
Q4 		$11.4M Buy
+145,234
New +$13.6M 2.84% 11

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stempoint Capital's NUVL Position: Q3 2025 in Review

Stempoint Capital sold out of Nuvalent (NUVL) in Q3 2025, closing a stake of 59,828 shares — an estimated $4.56M sold.

Stempoint Capital first reported a position in NUVL in Q4 2024 and held it in 3 quarters. The position peaked at $13.5M in Q1 2025. 196 funds tracked by Wall St. Rank hold NUVL as of Q3 2025.

  • Stempoint Capital reported no remaining Nuvalent position as of Q3 2025 after selling out during the quarter.
  • Stempoint Capital sold 59,828 Nuvalent shares in Q3 2025, an estimated $4.56M.
  • Stempoint Capital first reported a position in Nuvalent in Q4 2024 and held it in 3 quarters.
  • Stempoint Capital's Nuvalent position peaked at $13.5M in Q1 2025.
  • 196 funds tracked by Wall St. Rank held Nuvalent as of Q3 2025.

Based on Stempoint Capital's 13F filing for Q3 2025, filed 14 Nov 2025.